Integra LifeSciences Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Integra LifeSciences (IART) Tops Q3 EPS by 1c, Updates FY Guidance
November 3, 2015 8:03 AM ESTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.75, $0.01 better than the analyst estimate of $0.74. Revenue for the quarter came in at $226.4 million versus the consensus estimate of $224.08 million.
Integra LifeSciences sees FY2015 EPS of $3.05-$3.10, versus the consensus of $3.06. Integra LifeSciences sees FY2015... More



